These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32879150)

  • 21. Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes.
    Lee SJ; Lee DW; Kim KS; Lee IK
    Diabetes Res Clin Pract; 2001 Dec; 54 Suppl 2():S81-92. PubMed ID: 11733113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between serum cathepsin D levels and endothelial dysfunction in patients with chronic kidney disease.
    Ozkayar N; Piskinpasa S; Akyel F; Turgut D; Bulut M; Turhan T; Dede F
    Nefrologia; 2015; 35(1):72-9. PubMed ID: 25611836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial vasomotor dysfunction in the brachial artery predicts the short-term development of early stage renal dysfunction in patients with coronary artery disease.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Yano T; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Int J Cardiol; 2011 Apr; 148(2):183-8. PubMed ID: 19945185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Hemodialysis with Medium Cut-Off versus High-Flux Membranes on Endothelial Function of Patients with Chronic Kidney Disease.
    Armani RG; Carvalho AB; Vercia Rocha E Silva M; Verardino R; Bortolotto L; Canziani MEF
    Blood Purif; 2024; 53(7):565-573. PubMed ID: 38330931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4.
    Ghanavatian S; Diep LM; Bárány P; Heimbürger O; Seeberger A; Stenvinkel P; Rohani M; Agewall S
    Angiology; 2014 May; 65(5):443-9. PubMed ID: 23567479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Criteria of Flow-Mediated Vasodilation for Normal Endothelial Function and Nitroglycerin-Induced Vasodilation for Normal Vascular Smooth Muscle Function of the Brachial Artery.
    Maruhashi T; Kajikawa M; Kishimoto S; Hashimoto H; Takaeko Y; Yamaji T; Harada T; Han Y; Aibara Y; Mohamad Yusoff F; Hidaka T; Kihara Y; Chayama K; Nakashima A; Goto C; Tomiyama H; Takase B; Kohro T; Suzuki T; Ishizu T; Ueda S; Yamazaki T; Furumoto T; Kario K; Inoue T; Koba S; Watanabe K; Takemoto Y; Hano T; Sata M; Ishibashi Y; Node K; Maemura K; Ohya Y; Furukawa T; Ito H; Ikeda H; Yamashina A; Higashi Y
    J Am Heart Assoc; 2020 Jan; 9(2):e013915. PubMed ID: 31910779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.
    Yilmaz MI; Saglam M; Caglar K; Cakir E; Sonmez A; Ozgurtas T; Aydin A; Eyileten T; Ozcan O; Acikel C; Tasar M; Genctoy G; Erbil K; Vural A; Zoccali C
    Am J Kidney Dis; 2006 Jan; 47(1):42-50. PubMed ID: 16377384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between flow-mediated vasodilation and cardiovascular risk factors in a large community-based study.
    Maruhashi T; Soga J; Fujimura N; Idei N; Mikami S; Iwamoto Y; Kajikawa M; Matsumoto T; Hidaka T; Kihara Y; Chayama K; Noma K; Nakashima A; Goto C; Tomiyama H; Takase B; Yamashina A; Higashi Y
    Heart; 2013 Dec; 99(24):1837-42. PubMed ID: 24153417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endothelial and kidney function in women with a history of preeclampsia and healthy parous controls: A case control study.
    Lopes van Balen VA; Spaan JJ; Cornelis T; Heidema WM; Scholten RR; Spaanderman MEA
    Microvasc Res; 2018 Mar; 116():71-76. PubMed ID: 29126987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low flow-mediated constriction: prevalence, impact and physiological determinant.
    Harrison M; Parkhurst K; Tarumi T; Lin HF; Tanaka H
    Clin Physiol Funct Imaging; 2011 Sep; 31(5):394-8. PubMed ID: 21771260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uricemia and homocysteinemia: nontraditional risk factors in the early stages of chronic kidney disease--preliminary data.
    Lai S; Mariotti A; Coppola B; Lai C; Aceto P; Dimko M; Galani A; Innico G; Frassetti N; Mangiulli M; Cianci R
    Eur Rev Med Pharmacol Sci; 2014; 18(7):1010-7. PubMed ID: 24763881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between kidney disease and endothelial function in peripheral artery disease.
    Chong KC; Owens CD; Park M; Alley HF; Boscardin WJ; Conte MS; Gasper WJ; Grenon SM
    J Vasc Surg; 2014 Dec; 60(6):1605-11. PubMed ID: 25441679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients.
    Ashokachakkaravarthy K; Rajappa M; Parameswaran S; Satheesh S; Priyadarshini G; Mohan Raj PS; Revathy G; Priyadarssini M
    Int Urol Nephrol; 2020 Jul; 52(7):1321-1328. PubMed ID: 32409974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients.
    Chitalia N; Recio-Mayoral A; Kaski JC; Banerjee D
    Atherosclerosis; 2012 Jan; 220(1):265-8. PubMed ID: 22071357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Resveratrol on Endothelial Function in Patients with CKD and Diabetes: A Randomized Controlled Trial.
    Gimblet CJ; Kruse NT; Geasland K; Michelson J; Sun M; Mandukhail SR; Wendt LH; Eyck PT; Pierce GL; Jalal DI
    Clin J Am Soc Nephrol; 2024 Feb; 19(2):161-168. PubMed ID: 37843843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular Inflammation Evaluated by [18F]-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Is Associated With Endothelial Dysfunction.
    Honda A; Tahara N; Nitta Y; Tahara A; Igata S; Bekki M; Nakamura T; Sugiyama Y; Kaida H; Kurata S; Fujimoto K; Abe T; Enomoto M; Adachi H; Narula J; Yamagishi S; Fukumoto Y
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1980-8. PubMed ID: 27386941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total protein intake and subsequent risk of chronic kidney disease: the Circulatory Risk in Communities Study.
    Kubo S; Imano H; Muraki I; Kitamura A; Noda H; Cui R; Maruyama K; Yamagishi K; Umesawa M; Shimizu Y; Hayama-Terada M; Kiyama M; Okada T; Iso H
    Environ Health Prev Med; 2023; 28():32. PubMed ID: 37211392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular risk factors and systemic endothelial function in patients with cirrhosis.
    Berzigotti A; Erice E; Gilabert R; Reverter E; Abraldes JG; García-Pagan JC; Bosch J
    Am J Gastroenterol; 2013 Jan; 108(1):75-82. PubMed ID: 23147518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arterial stiffness but not endothelial dysfunction is associated with multidrug antihypertensive therapy and nondipper blood pressure pattern in kidney transplant recipients.
    Kolonko A; Bartmańska M; Słabiak-Błaż N; Kuczera P; Kujawa-Szewieczek A; Ficek R; Owczarek AJ; Chudek J; Więcek A
    Medicine (Baltimore); 2018 Sep; 97(36):e11870. PubMed ID: 30200072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.